Similar Posts
Exploring Compatibility Between Lipid-Based Formulations and Shell Materials
To ensure the physical and chemical stability of Lipid-Based Formulations (LBFs), it is essential to find a delicate balance between the formulation…
Enteric-Protected Solid Oral Dosage Form Development
Download Full Case Study Abstract: This comprehensive case study offers an exhaustive examination into the precise development of an enteric-protected solid oral…
How To Create An Bioavailability Enhanced Formulation
Utilizing strategies that conserve active pharmaceutical ingredient (API) quantities and pinpointing scalable formulation technologies suitable for boosting drug solubility and augmenting oral…
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Customer Requirements for Oral Dose Development
Pharmaceutical developers aim for cost-effective oral medications that work well. This can be challenging, requiring an understanding of client, patient, and provider…
Translating Lab Discoveries: Preclinical to First-in-Human Development.
Overview Drug developers have to take into account several factors to position a pre-clinical drug candidate successfully for first-in-human clinical trials. This executive summary will outline…
